Virtual Environment With Biofeedback to Promote Awareness of Relapse Risk Among Chemically Dependent Individuals

NCT ID: NCT02535858

Last Updated: 2015-08-31

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 80 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2007-11-30
• Study Completion Date: 2008-05-31

Brief Summary

Anxiety is one of the major influences on relapse and substance abuse treatment dropout. Chemically dependent individuals need to be aware of their emotional state in situations that jeopardise their treatment. The current therapeutic resources still subjective and with limited treatment success. This research presents a developed virtual environment (VE) simultaneously connected to a physiological signals device acquisition that allows, through a biofeedback, the chemically dependents consciousness on their vulnerability front different situations of 'risk', without a direct assessment of the therapist. Developed in 3ds Max® software, the VE is composed of scenarios and objects that are in the habit of the chemically dependent individual's daily life. The interaction with the environment is accomplished using a Human-Computer Interface (HCI) that converts incoming physiological signals indicating anxiety state into commands that change the scenes. Anxiety is characterized by the average variability from both heart and respiratory rate of 30 volunteers undergoing stress environment situations. To evaluate the effectiveness of the VE as a biofeedback of chemically dependent's vulnerability front situations of risk, a total of 50 volunteers who were drug users, monitored by 10 therapists, were enrolled. Prior VE, the results demonstrated a poor correlation between the therapists' predictions and those of the chemically dependent individuals. After exposure to the VE, there was a significant increase of 73% in awareness of the risks of relapse by the chemically dependent individuals, confirming the hypothesis that the VE coupled to the biofeedback device may assist the therapist with treatment.

Detailed Description

2.1 Ethical approval Approval was obtained from the Local Ethics Committee (CAAE-0094.0.237.000-07, process CEP/UMC-093/2007) for the participants. They had been informed about the methodology and confidentiality of their personal information. The participants were informed about the methodology and confidentiality of their personal information. All procedures were performed after written informed consent from all participants.

2.2 Study Participants To determine the limits between normal and emotional anxious, thirty volunteers male's adults (GL) with age range between 20 and 50 years were recruited. None of them had any pathology associated with anxiety or psychiatric disorders, and none was drugs user or taking medication. Three mental health professionals (PG1), specialized in chemical dependency, evaluated the emotional state of the volunteers.

A second group has fifty adult volunteers (DG) (mean age of 35±10.02 years) ongoing outpatient chemical dependency clinic [treatment average's population: 5 months and 14 days]. The patients were abstained from drugs use for at least two months, and they were selected to test the VE. None of the DG's participants had any pathology associated with anxiety or psychiatric disorders, and none was taking medications. The DG volunteers were narcotic users of two or more illicit drugs, such as alcohol, marijuana, tobacco, cocaine and crack cocaine. Addiction for alcohol and tobacco were 72% and 56% respectively. The group's percentage for using psychoactive drugs were, 70% for cocaine and crack cocaine and 32% for marijuana.

For this group, 10 mental health professionals (PG2), therapists, specialized in chemical dependency and responsible for monitoring the group's treatment assessed their emotional states.

To elaborate the scenarios and characterize the characters in the virtual environment (VE), another eight specialists professionals (PG3) from the chemical dependency field recommended situations, places, objects, signs, or cues thought to trigger craving.

2.4 Testing Protocol Prior CDI to the test, the therapist answered a questionnaire identifying the situations of risk presented in the VE that could lead the patient to relapse. The same questionnaire was also completed by the CDI before and after the VE test. In addition, this application was structured based on risk factors survey.

The questions presented are listed below:

1. If you receive a phone call from a friend that is a drug user, would it stimulate you to take drugs?

2. If you walk on places that used to be selling drugs areas, would you relapse by any chance?

3. If a colleague invites you to have drinks, would you be favored by taking drugs?

4. Family issues or situations where the family is absent, would it contribute to your relapse?

5. Would you relapse if you had the chance of going party or places that might have drugs?

6. A friendship that is a drug user and can offer it to you would trigger your wishes for having drugs? The questionnaire and VE test were applied to each CDI in a single day on mornings. The patients were present with their therapists while performing the test.

The test was conducted in a comfortable room that was part of a therapeutic community for CDIs. This room held the test equipment, a support table for the equipment, and chairs for the patient and therapist. Communication during the test was not recommended. Extra care was taken to avoid tests' interruptions including disturbance caused by equipment (air conditioning, audio, etc.) as well as people entering at the exam room. Regarding the sensors, the cardiac frequency meter was placed on the distal phalanx of the little finger and the respiratory rate (RR) sensor near the right nostril using a headset support. The CDIs were informed that the outcome of each situation presented in the VE would correspond to their physiological state when facing the risk situations. Their questions were answered, and only their emotions were shown to influence the scenarios. The test started with the volunteers watching a desired film selected by themselves where the basal levels from both physiological signals were simultaneously acquired. It was followed by the introduction of the developed VE where both heart and respiratory rates were measured between minutes and compared with the previously acquired baseline levels. The script automatically selected the scenes depending on the identified emotional state. When the state was identified as anxious, the program changed the scene, showing the character using drugs. Otherwise, the plot proceeded.

Conditions

Anxiety

Keywords

Anxiety

Study Design

• Allocation Method: NON_RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: PREVENTION
• Blinding Strategy: NONE

Study Groups

Heart and respiratory rate and video

To determine the limits between normal and emotional anxious, thirty volunteers male's adults (GL) with age range between 20 and 50 years were recruited. None of them had any pathology associated with anxiety or psychiatric disorders, and none was drugs user or taking medication.

Group Type: EXPERIMENTAL

Heart and respiratory rate and video

Intervention Type: DEVICE

Anxiety is characterized by the average variability from both heart and respiratory rate of 30 volunteers undergoing stress environment situations.

Heart and respiratory rate and VE

A second group has fifty adult volunteers (DG) ongoing outpatient chemical dependency clinic \[treatment average's population: 5 months and 14 days\]. The patients were abstained from drugs use for at least two months, and they were selected to test the VE. None of the DG's participants had any pathology associated with anxiety or psychiatric disorders, and none was taking medications. The DG volunteers were narcotic users of two or more illicit drugs, such as alcohol, marijuana, tobacco, cocaine and crack cocaine. Addiction for alcohol and tobacco were 72% and 56% respectively. The group's percentage for using psychoactive drugs were, 70% for cocaine and crack cocaine and 32% for marijuana.

Group Type: EXPERIMENTAL

Heart and respiratory rate and VE

Intervention Type: DEVICE

To evaluate the effectiveness of the virtual environment (VE) as a biofeedback of chemically dependent's vulnerability front situations of risk, a total of 50 volunteers who were drug users, monitored by 10 therapists, were enrolled.

Interventions

Heart and respiratory rate and VE

To evaluate the effectiveness of the virtual environment (VE) as a biofeedback of chemically dependent's vulnerability front situations of risk, a total of 50 volunteers who were drug users, monitored by 10 therapists, were enrolled.

Intervention Type: DEVICE

Heart and respiratory rate and video

Anxiety is characterized by the average variability from both heart and respiratory rate of 30 volunteers undergoing stress environment situations.

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

• Volunteers (DG) ongoing outpatient chemical dependency clinic [treatment average's population: 5 months and 14 days].
• The patients were abstained from drugs use for at least two months, and they were selected to test the VE.
• None of the DG's participants had any pathology associated with anxiety or psychiatric disorders, and none was taking medications.
• The DG volunteers were narcotic users of two or more illicit drugs, such as alcohol, marijuana, tobacco, cocaine and crack cocaine.

Exclusion Criteria

• The patients were not abstained from drugs use for at least two months

• Minimum Eligible Age: 20 Years
• Maximum Eligible Age: 50 Years
• Eligible Sex: MALE
• Accepts Healthy Volunteers: No

Sponsors

University of Mogi das Cruzes

OTHER

Sponsor Role: lead

Responsible Party

Annie France Frère Slaets

PhD

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Annie F. Frère, PhD

Role: PRINCIPAL_INVESTIGATOR

University of Mogi Cruzes

Locations

University of Mogi das Cruzes

Mogi das Cruzes, São Paulo, Brazil

Countries

Brazil

Other Identifiers

0094.0.237.000-07

Identifier Type: -

Identifier Source: org_study_id